Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Cedric Francois. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Cedric Francois har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:APLS / Apellis Pharmaceuticals, Inc. Chief Executive Officer, Director 307.946
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Cedric Francois. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb APLS / Apellis Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i APLS / Apellis Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
Insidersalg APLS / Apellis Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i APLS / Apellis Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-08-28 APLS Francois Cedric 49.963 28,3900 49.963 28,3900 1.418.450 15 24.8500 -176.868 -12,47
2025-08-27 APLS Francois Cedric 175.037 28,1900 175.037 28,1900 4.934.293
2025-01-29 APLS Francois Cedric 2.824 29,5236 2.824 29,5236 83.375
2025-01-22 APLS Francois Cedric 13.551 30,4255 13.551 30,4255 412.296
2025-01-17 APLS Francois Cedric 6.007 29,9582 6.007 29,9582 179.959
2025-01-13 APLS Francois Cedric 6.247 28,7021 6.247 28,7021 179.302
2024-03-01 APLS Francois Cedric 28.868 62,2130 28.868 62,2130 1.795.965
2024-03-01 APLS Francois Cedric 41.704 62,9631 41.704 62,9631 2.625.813
2024-03-01 APLS Francois Cedric 62.503 64,2573 62.503 64,2573 4.016.274
2024-03-01 APLS Francois Cedric 116.512 64,9163 116.512 64,9163 7.563.528
2024-03-01 APLS Francois Cedric 413 65,6800 413 65,6800 27.126
2024-02-12 APLS Francois Cedric 3.962 67,7669 3.962 67,7669 268.492
2024-01-29 APLS Francois Cedric 2.843 64,1382 2.843 64,1382 182.345
2024-01-22 APLS Francois Cedric 13.431 64,9960 13.431 64,9960 872.961
2024-01-16 APLS Francois Cedric 7.851 66,8086 7.851 66,8086 524.514
2023-11-21 APLS Francois Cedric 5.000 48,8000 5.000 48,8000 244.000
2023-09-01 APLS Francois Cedric 139.716 41,7025 139.716 41,7025 5.826.506
2023-09-01 APLS Francois Cedric 10.284 42,4400 10.284 42,4400 436.453
2020-01-15 APLS Francois Cedric 26.076 42,1590 26.076 42,1590 1.099.338
2020-01-15 APLS Francois Cedric 4.562 42,5470 4.562 42,5470 194.099

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Cedric Francois som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-29 2025-08-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -49.963 307.946 -13,96 28,39 -1.418.450 8.742.587
2025-08-29 2025-08-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -175.037 357.909 -32,84 28,19 -4.934.293 10.089.455
2025-07-18 2025-07-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -19.725 331.605 -5,61 20,21 -398.735 6.703.296
2025-07-18 2025-07-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 8.997 351.330 2,63 4,31 38.777 1.514.232
2025-07-16 2025-07-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.900 342.333 -0,55 20,09 -38.168 6.876.922
2025-07-16 2025-07-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 800 344.233 0,23 4,31 3.448 1.483.644
2025-07-16 2025-07-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -137.465 343.433 -28,59 20,19 -2.774.923 6.932.676
2025-07-16 2025-07-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 65.203 480.898 15,69 4,31 281.025 2.072.670
2025-01-30 2025-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -2.824 415.695 -0,67 29,52 -83.375 12.272.813
2025-01-23 2025-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -13.551 418.519 -3,14 30,43 -412.296 12.733.650
2025-01-21 2025-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 130.662 432.070 43,35
2025-01-21 2025-01-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -6.007 301.408 -1,95 29,96 -179.959 9.029.641
2025-01-14 2025-01-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -6.247 307.415 -1,99 28,70 -179.302 8.823.456
2024-11-01 2024-11-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other -182.146 472.065 -27,84
2024-03-05 2024-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -413 313.662 -0,13 65,68 -27.126 20.601.320
2024-03-05 2024-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -116.512 314.075 -27,06 64,92 -7.563.528 20.388.587
2024-03-05 2024-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -62.503 430.587 -12,68 64,26 -4.016.274 27.668.358
2024-03-05 2024-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -41.704 493.090 -7,80 62,96 -2.625.813 31.046.475
2024-03-05 2024-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -28.868 534.794 -5,12 62,21 -1.795.965 33.271.139
2024-03-05 2024-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 200.000 563.662 55,00 4,31 862.000 2.429.383
2024-03-05 2024-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 50.000 363.662 15,94 3,76 188.000 1.367.369
2024-02-13 2024-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -3.962 313.662 -1,25 67,77 -268.492 21.255.901
2024-01-31 2024-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -2.843 317.624 -0,89 64,14 -182.345 20.371.832
2024-01-23 2024-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -13.431 320.467 -4,02 65,00 -872.961 20.829.073
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -7.851 333.898 -2,30 66,81 -524.514 22.307.258
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 72.094 341.749 26,74
2023-11-21 2023-11-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -5.000 269.655 -1,82 48,80 -244.000 13.159.164
2023-09-20 2023-09-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift 150.000 804.211 22,93
2023-09-20 2023-09-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -150.000 274.655 -35,32
2023-09-01 2023-09-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -10.284 424.655 -2,36 42,44 -436.453 18.022.358
2023-09-01 2023-09-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -139.716 434.939 -24,31 41,70 -5.826.506 18.138.044
2023-09-01 2023-09-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 300.000 574.655 109,23 2,67 801.000 1.534.329
2023-05-25 2023-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift 20.000 654.211 3,15
2023-05-25 2023-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -20.000 274.655 -6,79
2023-05-18 2023-05-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 20.000 294.655 7,28 2,67 53.400 786.729
2023-05-18 2023-05-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.120 274.655 -0,77 87,67 -185.869 24.080.075
2023-05-18 2023-05-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.528 276.775 -2,65 87,02 -655.059 24.083.936
2023-05-18 2023-05-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.007 284.303 -1,05 85,90 -258.305 24.421.969
2023-05-18 2023-05-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -14.611 287.310 -4,84 85,01 -1.242.065 24.423.907
2023-05-18 2023-05-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.800 301.921 -0,59 83,84 -150.921 25.314.566
2023-05-18 2023-05-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -934 303.721 -0,31 83,17 -77.682 25.260.810
2023-05-18 2023-05-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 30.000 304.655 10,92 2,67 80.100 813.429
2023-04-28 2023-04-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift 382.946 382.946
2023-04-28 2023-04-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -382.946 274.655 -58,23
2023-04-20 2023-04-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 20.000 657.601 3,14 2,67 53.400 1.755.795
2023-04-20 2023-04-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -30.000 637.601 -4,49 82,02 -2.460.720 52.298.584
2023-04-20 2023-04-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 30.000 667.601 4,71 2,67 80.100 1.782.495
2023-04-05 2023-04-05 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift 26.990 634.211 4,44
2023-04-05 2023-04-05 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -26.990 637.601 -4,06
2023-04-05 2023-04-04 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift 380.000 607.221 167,24
2023-04-05 2023-04-04 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -380.000 664.591 -36,38
2023-04-05 2023-04-03 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift 227.221 227.221
2023-04-05 2023-04-03 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -227.221 1.044.591 -17,87
2023-03-23 2023-03-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.221 1.271.812 0,57 13,85 100.011 17.614.596
2023-03-23 2023-03-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 100.000 1.264.591 8,59 3,76 376.000 4.754.862
2023-03-23 2023-03-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 20.000 1.164.591 1,75 2,67 53.400 3.109.458
2023-03-23 2023-03-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -30.000 1.144.591 -2,55 62,74 -1.882.332 71.816.676
2023-03-23 2023-03-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 30.000 1.174.591 2,62 2,67 80.100 3.136.158
2023-03-01 2023-02-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 100.000 1.144.591 9,57 3,76 376.000 4.303.662
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.602 1.044.591 -0,15 58,50 -93.717 61.108.574
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 13.908 1.046.193 1,35
2023-02-14 2023-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -3.958 1.032.285 -0,38 51,21 -202.689 52.863.315
2023-01-30 2023-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.879 1.036.243 -0,28 52,77 -151.925 54.682.543
2023-01-24 2023-01-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -9.453 1.039.122 -0,90 52,05 -492.029 54.086.300
2023-01-17 2023-01-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 83.447 1.048.575 8,65
2022-12-21 2022-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -24.449 965.128 -2,47 52,07 -1.273.052 50.253.925
2022-12-21 2022-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.751 989.577 -0,38 51,97 -194.931 51.426.140
2022-12-21 2022-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.688 993.328 0,68 14,95 99.986 14.850.254
2022-12-21 2022-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.000 986.640 1,54 3,76 56.400 3.709.766
2022-12-21 2022-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 28.200 971.640 2,99 2,67 75.294 2.594.279
2022-12-21 2022-04-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other -12.500 943.440 -1,31
2022-02-14 2022-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.523 955.940 -0,26 47,12 -118.884 45.043.893
2022-02-10 2021-06-16 5 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -80.000 854.243 -8,56
2022-02-01 2022-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.024 1.338.463 -0,15 38,59 -78.106 51.651.287
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 150.672 150.672
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 106.244 1.340.487 8,61
2021-07-22 2021-07-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -14.410 375.538 -3,70
2021-07-22 2021-07-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 14.410 1.234.243 1,18 4,31 62.107 5.319.587
2021-02-11 2021-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.523 1.219.833 -0,21 47,72 -120.398 58.210.431
2021-02-04 2020-12-29 5 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift 300.000 300.000
2021-02-04 2020-12-29 5 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -300.000 813.079 -26,95
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 150.000 150.000
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 12.500 1.222.356 1,03
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 25.000 1.209.856 2,11
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -31.992 389.948 -7,58
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -39.785 273.840 -12,69
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 31.992 1.184.856 2,78 4,31 137.886 5.106.729
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 39.785 1.152.864 3,57 3,76 149.592 4.334.769
2020-12-16 2020-12-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.113.079 -0,45 52,16 -260.800 58.058.201
2020-12-02 2020-12-01 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -40.000 313.625 -11,31
2020-12-02 2020-12-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 40.000 1.118.079 3,71 3,76 150.400 4.203.977
2020-11-17 2020-11-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.078.079 -0,46 39,38 -196.900 42.454.751
2020-10-16 2020-10-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.083.079 -0,46 34,46 -172.300 37.322.902
2020-09-16 2020-09-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.088.079 -0,46 30,96 -154.800 33.686.926
2020-08-21 2020-08-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.457 1.093.079 -0,32 30,00 -103.710 32.792.370
2020-08-20 2020-08-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.543 1.096.536 -0,14 30,00 -46.290 32.896.080
2020-07-16 2020-07-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.098.079 -0,45 32,12 -160.600 35.270.297
2020-06-16 2020-06-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.103.079 -0,45 30,21 -151.050 33.324.017
2020-05-19 2020-05-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.108.079 -0,45 29,92 -149.600 33.153.724
2020-04-17 2020-04-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.113.079 -0,45 29,77 -148.850 33.136.362
2020-03-18 2020-03-17 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -30.637 0 -100,00
2020-03-18 2020-03-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 30.637 1.083.704 2,91 2,14 65.563 2.319.127
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -30.637 30.637 -50,00
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -300 1.053.067 -0,03 23,86 -7.158 25.126.179
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.212 1.053.367 -0,30 22,28 -71.557 23.466.910
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.065 1.056.579 -1,41 21,58 -325.088 22.799.918
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12.060 1.071.644 -1,11 20,69 -249.558 22.175.529
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -700 1.083.704 -0,06 22,29 -15.600 24.151.427
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.192 1.084.404 -0,20 21,57 -47.279 23.389.510
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.108 1.086.596 -0,19 20,73 -43.695 22.522.962
2020-03-18 2020-03-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 30.637 1.088.704 2,90 2,14 65.563 2.329.827
2020-02-20 2020-02-19 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -30.637 61.274 -33,33
2020-02-20 2020-02-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 30.637 1.058.067 2,98 2,14 65.563 2.264.263
2020-02-20 2020-02-18 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -30.637 91.911 -25,00
2020-02-20 2020-02-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.027.430 -0,48 40,67 -203.330 41.781.468
2020-02-20 2020-02-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -30.637 1.032.430 -2,88 40,66 -1.245.792 41.981.701
2020-02-20 2020-02-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 30.637 1.063.067 2,97 2,14 65.563 2.274.963
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 206.250 206.250
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 34.375 1.066.805 3,33
2020-01-21 2020-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -30.637 122.548 -20,00
2020-01-21 2020-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 30.637 1.032.430 3,06 2,14 65.563 2.209.400
2020-01-17 2020-01-15 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -30.638 153.185 -16,67
2020-01-17 2020-01-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 30.638 1.001.793 3,15 2,14 65.565 2.143.837
2020-01-17 2020-01-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.001.793 -0,50 41,47 -207.350 41.544.356
2020-01-17 2020-01-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -4.562 1.006.793 -0,45 42,55 -194.099 42.836.022
2020-01-17 2020-01-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -26.076 1.011.355 -2,51 42,16 -1.099.338 42.637.715
2019-12-17 2019-12-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.006.793 -0,49 27,95 -139.750 28.139.864
2019-11-18 2019-11-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 1.011.793 -0,49 27,28 -136.405 27.602.725
2019-10-16 2019-10-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.524 1.016.793 -0,35 26,61 -93.784 27.059.912
2019-10-16 2019-10-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.476 1.020.317 -0,14 25,59 -37.766 26.106.851
2019-09-17 2019-09-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -260 1.021.793 -0,03 27,17 -7.064 27.762.116
2019-09-17 2019-09-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.740 1.022.053 -0,46 26,56 -125.885 27.143.684
2019-08-26 2019-08-23 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -37.505 478.200 -7,27
2019-08-26 2019-08-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 37.505 1.026.793 3,79 2,67 100.138 2.741.537
2019-08-16 2019-08-15 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -10.000 183.823 -5,16
2019-08-16 2019-08-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.246 989.288 -0,23 27,00 -60.642 26.710.776
2019-08-16 2019-08-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.754 991.534 -0,78 26,74 -207.365 26.516.594
2019-08-16 2019-08-15 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 10.000 999.288 1,01 2,14 21.400 2.138.476
2019-07-01 2019-06-27 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -275.000 193.823 -58,66
2019-07-01 2019-06-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 275.000 989.288 38,50 2,14 588.500 2.117.076
2019-02-12 2019-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 281.000 281.000
2018-05-09 2018-05-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other 384.292 714.288 116,45
2018-02-21 2018-02-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 280.000 280.000
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
894.403
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
798.818
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
894.403
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
798.818
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)